JACOBS LEVY EQUITY MANAGEMENT, INC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$279,000
+114.6%
79,700
+444.4%
0.01%
+66.7%
Q3 2017$130,000
-35.3%
14,640
-23.3%
0.00%
-25.0%
Q1 2017$201,000
-71.4%
19,080
+12.6%
0.00%
-66.7%
Q1 2014$702,000
+12.7%
16,950
+5.3%
0.01%
+33.3%
Q4 2013$623,000
+83.8%
16,090
+65.9%
0.01%
+50.0%
Q3 2013$339,0009,7000.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2019
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders